EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment

Patrick D McGorry, John Cocks, Paddy Power, Peter Burnett, Susy Harrigan, Tim Lambert

Schizophrenia Research and Treatment · 2011

DOI: 10.1155/2011/631690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research and Treatment, 2011. Verfasst von Patrick D McGorry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Orygen Youth Health Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, VIC 3052, Australia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Janssen-Cilag Australia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients experiencing a first psychotic episode have high rates of extrapyramidal symptoms (EPSs) when treated with the doses of neuroleptics used in multiepisode or chronic schizophrenia. There is some evidence that lower doses may be equally, if not more, effective but less toxic in this population. Here, we report the results of a biphasic open label trial designed to assess the efficacy, safety, and tolerability of low-dose (2–4 mg/day) risperidone treatment in a group of 96 first-episode nonaffective psychosis patients. At the end of the trial, 62% of patients met the response criteria although approximately 80% had achieved a response at some time during the study. Reports of EPS remained low, and there were no dystonic reactions. We conclude that even at a dose of 2 mg/day, risperidone was highly effective in reducing acute symptomatology in a real world sample of young first-episode psychosis patients.

Autor:innen und Institutionen

  • Orygen Youth Health Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, VIC 3052, Australia.

Förderung

  • Janssen-Cilag Australia

Zitieren

APA

McGorry, P. D., Cocks, J., Power, P., Burnett, P., Harrigan, S., & Lambert, T. (2011). Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment. Schizophrenia Research and Treatment. https://doi.org/10.1155/2011/631690

Vancouver

McGorry PD, Cocks J, Power P, Burnett P, Harrigan S, Lambert T. Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment. Schizophrenia Research and Treatment. 2011. doi:10.1155/2011/631690

BibTeX
@article{McGorry2011,
  author = {McGorry, Patrick D and Cocks, John and Power, Paddy and Burnett, Peter and Harrigan, Susy and Lambert, Tim},
  title = {Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment},
  journal = {Schizophrenia Research and Treatment},
  year = {2011},
  doi = {10.1155/2011/631690}
}
Kostenlos starten →